Traws Pharma's top three insider shareholders as of May 04, 2026 are Nikolay Savchuk (Chief Operating Officer, 2.53Mn shares), Iain D. Dukes (Executive Chairman, 1.65Mn shares), Iain D. Dukes (Chief Executive Officer, 171.13K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Nikolay Savchuk | Chief Operating Officer | 0 | 2,530,632 | 03 Apr, 2024 |
| Iain D. Dukes | Executive Chairman | 0 | 1,645,100 | 03 Apr, 2024 |
| Iain D. Dukes | Chief Executive Officer | 171,130 | 0 | 16 Dec, 2025 |
| Nikolay Savchuk | Chief Operating Officer | 150,606 | 0 | 16 Dec, 2025 |
| Charles David Pauza | Chief Science Officer Virology | 115,971 | 0 | 16 Dec, 2025 |
| Robert Redfield | Chief Medical Officer | 113,919 | 0 | 16 Dec, 2025 |
| Werner Cautreels | Chief Executive Officer | 109,222 | 0 | 16 Dec, 2025 |
| Steven M Fruchtman | President, Chief Executive Off | 74,792 | 0 | 15 Mar, 2024 |
| Mark Patrick Guerin | Cfo | 39,255 | 0 | 20 Jun, 2024 |
| Abraham N. Oler | Svp Corp Dev Gen Counsel | 24,514 | 0 | 31 Jan, 2022 |
| James J Marino | - | 21,334 | 0 | 28 Sep, 2021 |
| Abraham N. Oler | Svp Corp Dev Gen Counsel | 18,514 | 0 | 23 Nov, 2021 |
| Mark S. Md Gelder | Chief Medical Officer | 10,487 | 0 | 08 Feb, 2023 |
| Mary Teresa Shoemaker | - | 6,292 | 0 | 16 Dec, 2025 |
| Jack E Stover | - | 6,165 | 0 | 16 Dec, 2025 |
| Trafford Clarke | - | 6,157 | 0 | 16 Dec, 2025 |
| John Harold Leaman | - | 4,058 | 0 | 16 Dec, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 08 Mar, 2026 | Nikolay Savchuk | Stock Option (right to buy) | A | 96,899 | $0.00 | 96,899 | D | A |
| 08 Mar, 2026 | John Harold Leaman | Stock Option (right to buy) | A | 33,435 | $0.00 | 33,435 | D | A |
| 08 Mar, 2026 | Charles David Pauza | Stock Option (right to buy) | A | 118,367 | $0.00 | 118,367 | D | A |
| 08 Mar, 2026 | Robert Redfield | Stock Option (right to buy) | A | 108,854 | $0.00 | 108,854 | D | A |
| 08 Mar, 2026 | Jack E Stover | Stock Option (right to buy) | A | 33,435 | $0.00 | 33,435 | D | A |
| 08 Mar, 2026 | Iain D. Dukes | Stock Option (right to buy) | A | 231,336 | $0.00 | 231,336 | D | A |
| 08 Mar, 2026 | Werner Cautreels | Stock Option (right to buy) | A | 31,258 | $0.00 | 31,258 | D | A |
| 08 Mar, 2026 | Mary Teresa Shoemaker | Stock Option (right to buy) | A | 33,435 | $0.00 | 33,435 | D | A |
| 08 Mar, 2026 | Trafford Clarke | Stock Option (right to buy) | A | 33,435 | $0.00 | 33,435 | D | A |
| 12 Dec, 2025 | Iain D. Dukes | Common Stock | A | 36,943 | $0.00 | 171,130 | D | A |
| 12 Dec, 2025 | Mary Teresa Shoemaker | Common Stock | A | 6,157 | $0.00 | 6,292 | D | A |
| 12 Dec, 2025 | Jack E Stover | Common Stock | A | 6,157 | $0.00 | 6,165 | D | A |
| 12 Dec, 2025 | John Harold Leaman | Common Stock | A | 4,058 | $0.00 | 4,058 | D | A |
| 12 Dec, 2025 | Robert Redfield | Common Stock | A | 16,419 | $0.00 | 113,919 | D | A |
| 12 Dec, 2025 | Werner Cautreels | Common Stock | A | 4,874 | $0.00 | 109,222 | D | A |
| 12 Dec, 2025 | Nikolay Savchuk | Common Stock | A | 16,419 | $0.00 | 150,606 | D | A |
| 12 Dec, 2025 | Charles David Pauza | Common Stock | A | 18,471 | $0.00 | 115,971 | D | A |
| 12 Dec, 2025 | Trafford Clarke | Common Stock | A | 6,157 | $0.00 | 6,157 | D | A |
| 12 Dec, 2025 | Werner Cautreels | Stock Option (right to purchase) | A | 19,496 | $0.00 | 19,496 | D | A |
| 12 Dec, 2025 | John Harold Leaman | Stock Option (right to purchase) | A | 16,234 | $0.00 | 16,234 | D | A |